Immune Killer Cells (IKC)

BIOLOGICAL2 trials

Sponsors

Ivy Life Sciences, Co., Ltd

Conditions

Hepatocellular Carcinoma by BCLC StageLiver CancerLung CancerNSCLC Stage IIIBNSCLC Stage IVNon-small Cell Lung Cancer (NSCLC) Stage IV

Phase 1

Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer

CompletedNCT03515252

Ivy Life Sciences, Co., LtdHepatocellular Carcinoma by BCLC Stage, Liver Cancer, Lung Cancer +2

Start: 2005-04-26End: 2007-06-07Updated: 2018-05-09

Phase 2

A Study to Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Target Therapy

CompletedNCT03499834

Ivy Life Sciences, Co., LtdNon-small Cell Lung Cancer (NSCLC) Stage IV

Start: 2017-12-05End: 2020-02-16Updated: 2020-04-16

Related Papers

Immune killer cells treatment for previously treated stage IV NSCLC patients.

2024-08-211 citations